Further, it has been demonstrated that imatinib activated CD8(+) T cells and induced regulatory T cell (T(reg) cell) apoptosis within the tumor by reducing tumor-cell expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (Ido) [12]. The gene discussed is IDO1; the disease is neoplasm.